Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Rhopressa on the Trabecular Meshwork in Ocular Hypertension or Glaucoma
NCT07588152Phase 4Recruiting
- Sponsor
- Indiana University
- Start
- Jun 2026
- Primary completion
- Jun 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of netarsudil in Glaucoma, ocular hypertension, sponsored by Indiana University. Started Jun 2026; status: recruiting.
02
Drugs
netarsudil
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NCT07588152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07588152.